Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...

Budget documents for Congress provide the most detailed look yet at how the Trump Administration hopes to reshape the ...

AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...

An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new ...